Frederic Mack
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
Journal: Journal of neuro-oncology
Published: May 21, 2019
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Journal: Lancet (London, England)
Published: April 26, 2018
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
Journal: Journal of cancer research and clinical oncology
Published: April 11, 2018
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.
Journal: Neuro-oncology
Published: November 10, 2017
The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma.
Journal: Journal of cancer research and clinical oncology
Published: May 09, 2016
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 16, 2016
Phase I trial of dovitinib (TKI258) in recurrent glioblastoma.
Journal: Journal of cancer research and clinical oncology
Published: March 02, 2016
Prognostic factors in recurrent glioblastoma patients treated with bevacizumab.
Journal: Journal of neuro-oncology
Published: September 14, 2015
Therapy of leptomeningeal metastasis in solid tumors.
Journal: Cancer treatment reviews
Published: September 01, 2015
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2015
18F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report.
Journal: Oncology letters
Published: December 09, 2014
Last Updated: 09/26/2026